Tc-3PRGD SPECT Predicts the Outcome of Endostar and Cisplatin Therapy in Xenograft Animals
Aims: Our study was designed to investigate the usefulness of 99m Tc-3PRGD 2 single-photon emission computed tomography (SPECT) for noninvasively monitoring the response of integrin α v β 3 expression to antiangiogenic treatment with endostar and cisplatin in xenograft animals. Methods: 99m Tc-3PRGD...
Main Authors: | Wei Sun, Guifu He, Mingming Zhang, Yi Zhao, Hongmei Yu, Yi Li, Wei Wu, Tiefeng Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-10-01
|
Series: | Dose-Response |
Online Access: | https://doi.org/10.1177/1559325819882544 |
Similar Items
-
Tc-3PRGD Scintimammography in Palpable and Nonpalpable Breast Lesions
by: Lin Liu, et al.
Published: (2014-07-01) -
Clinical Value of 99mTc-3PRGD2 Molecular Image in Evaluating Effect of Recombinant Endostatin
by: YANG Zhenhua, et al.
Published: (2018-05-01) -
Biometabolic Distribution of Tc-3PRGD2 and its Potential Value in Monitoring Chemotherapeutic Effects
by: Jian-Guo Wu, et al.
Published: (2015-12-01) -
Monitoring Apoptosis of Breast Cancer Xenograft After Paclitaxel Treatment With Tc-Labeled Duramycin SPECT/CT
by: Rui Luo, et al.
Published: (2016-01-01) -
Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update
by: Ting Jin, et al.
Published: (2018-04-01)